Release Date: 29/09/10 17:16 Summary: Director Appointment and Appendix 3X Price Sensitive: No Download Document 111.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%